Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 2 22:07

Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan

Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan

Dow JonesMay 1 23:11

Silk Road Medical Is Maintained at Neutral by Piper Sandler

Silk Road Medical Is Maintained at Neutral by Piper Sandler

Dow JonesMay 1 21:52

Piper Sandler Maintains Neutral on Silk Road Medical, Raises Price Target to $20

Piper Sandler analyst Adam Maeder maintains Silk Road Medical (NASDAQ:SILK) with a Neutral and raises the price target from $18 to $20.

BenzingaMay 1 21:42

Silk Road Medical Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 2.88% Piper Sandler $18 → $20 Maintains Neutral 03/07/2024 23.46% Argus Research → $24 Upgrades

BenzingaMay 1 21:41

Oppenheimer Reaffirms Their Buy Rating on Silk Road Medical (SILK)

TipRanksMay 1 19:55